期刊文献+

肠道菌群与药物相互作用机制的研究进展 被引量:9

Interaction between gut microbiota and drugs
下载PDF
导出
摘要 人类的皮肤、口腔、鼻咽部和肠道等部位定植着各种各样的微生物,这些微生物和其寄居环境一起组成了动态的微生态系统,其中肠道中的微生物数量庞大,种类繁多,与肠道环境一起形成了人体中最重要的微生态系统。肠道菌群与人体的共生关系使其在宿主的消化吸收、稳态维持、生理病理状态、药物吸收代谢等多个方面都有着巨大的影响。肠道菌群和药物之间存在复杂的相互作用,药物进入体内后会对肠道菌群的种类数量产生影响;肠道菌群会对中药成分及化学药物的药物成分产生活化、失活或毒化的代谢效果。本文阐述了肠道菌群-药物的相互影响,以及肠道菌群对药物代谢的影响机制。 A variety of microbial communities have colonized in human skin,mouth,nasopharynx,intestinal tract and other parts,constituting dynamic microecosystem together with their habitat environment,in which gut microbiota communities are overwhelming in number and variety,in consort with the intestinal environment,forming the most important microecosystem in human body.The symbiotic relationship between gut microbiota and human body greatly influences the host digestion and absorption,homeostasis maintenance,physiological and pathological status,drug metabolism and so on.There are complex interactions between gut microbiota and drugs,the number of species of gut microbiota will be affected after drugs enter the body.Gut microbiota exert activate,inactivate or toxicity metabolism effect on traditional Chinese medicine and chemical medicine.Based on literature review,this paper summarizes the interaction between gut microbiota and drugs,and the mechanism of the influence of gut microbiota on drug metabolism.
作者 张雅婷 孙月梅 张娟红 霍妍 李雪 李文斌 赵安鹏 王荣 ZHANG Ya-ting;SUN Yue-mei;ZHANG Juan-hong;HUO Yan;LI Xue;LI Wen-bin;ZHAO An-peng;WANG Rong(School of Pharmacy, Lanzhou University, Lanzhou 730000, China;Key Lab of the Plateau Medicine, the 940th Hospital of Joint Logistics Support Force, PLA,Lanzhou 730050, China)
出处 《中国药理学通报》 CAS CSCD 北大核心 2020年第12期1650-1655,共6页 Chinese Pharmacological Bulletin
基金 国家科技重大专项(No 2018ZX09J18109-001) 国家自然科学基金资助项目(No 81403004,81401552,81673508)。
关键词 肠道菌群 菌群动力学 药物代谢 中药成分 化学变化 相互作用 gut microbiota microbiota dynamics drug metabolism Chinese medicine chemical changes interaction
  • 相关文献

参考文献2

二级参考文献61

  • 1王瑞君.人体的胃肠道微生态系统和微生态失衡[J].渝西学院学报(自然科学版),2005,4(4):39-41. 被引量:15
  • 2张逊,姚文,朱伟云.肠道大豆异黄酮降解菌研究进展[J].世界华人消化杂志,2006,14(10):973-978. 被引量:22
  • 3董庆洁,邵仕香,葛卿,缴佩佩.微波辅助萃取槐米中芦丁工艺条件的探讨[J].中草药,2006,37(10):1510-1511. 被引量:8
  • 4Rathee P, Chaudhary H, Rathee S, et al. Mechanism of action of flavonoids as anti-inflammatory agents: a review[J]. Inflamm Al- lergy Drug Targets,2009,8 (3) :229.
  • 5Grassi D, Desideri G, Croce G, et al. Flavonoids, vascular func- tion and cardiovascular protection [ J ]. Curr Pharm Des ,2009,15 (10) :1072.
  • 6Setchell K D, Brown N M, Lydeking-Olsen E. The clinical im- portance of the metabolite equal a clue to the effectiveness of soy and its isoflavones[ J]. J Nutr,2002,132 (12) :3577.
  • 7Lee Y H, Kwak J, Choi H K, et al. EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity [ J ]. Int J Mol Med,2012, 30(1 ) :69.
  • 8Ley R E, Peterson D A, Gordon J I. Ecological and evolutionary forces shaping microbial diversity in the human intestine [ J ]. Cell, 2006, 124(4) :837.
  • 9Qin J, Li R, Arumugam M, et al. A human gut microbial gene catalogue established by metagenomic sequencing [ J ]. Nature, 2010, 464(7285) : 59.
  • 10Wang Z, Elizabeth K, Brian J. B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease [ J 1. Nature, 2011,472(7341) : 57.

共引文献39

同被引文献147

引证文献9

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部